Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider

ConclusionsMedical providers were aware that their patients who were receiving a stable dose of SRL regularly experienced acromegaly symptoms. Addressing discordance in patient- and medical provider-reported frequency and severity of acromegaly symptoms and injection site reactions by facilitating better communication may improve care of acromegaly patients.
Source: Pituitary - Category: Endocrinology Source Type: research